CClinicalTrials.gg
RecruitingNCT06341322Updated Apr 2, 2024

Using Behavioural and Cultural Insights to Increase Colorectal Cancer Home-testing in Croatia

An interventional study of Standard letter and Behaviorally informed letter in Colorectal Cancer and Behavior Change, sponsored by Veerle Snijders. Recruiting at 1 site in Croatia. Open to participants aged 50 Years to 74 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-04-02.

Sponsored by Veerle Snijders · Not applicable, Interventional, and Screening

From the registry’s dates

  • Primary completion was expected by Apr 2024, 2 years 6 months ago, but the record still lists the study as recruiting.
  • Started Mar 2024; still recruiting 2 years 7 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
13,000
Allocation
Randomized
Ages
50 Years to 74 Years
Sex
All
01

Study summary

Colorectal cancer (CRC) is one of the leading causes of death in Croatia. An average of 3600 cases are diagnosed and an average of 2100 people die from the disease every year. Since 2007, Croatia has invited every man and woman aged 50-74 to participate in the home testing screening programme every two years. Currently only around 36% of the invited request the test-kit and 25% complete the home testing procedure, far below the target of 40-60%.

The Croatian Institute of Public Health with technical support from World Health Organization (WHO) Regional Office for Europe is undertaking a mixed-methods research study with the aim to increase the completion of colorectal cancer home testing and improve our knowledge of the barriers and drivers to do so. The study has a quantitative and a qualitative component:

  1. Quantitative: testing the introduction of a reminder letter to encourage people to respond to the initial invite to participate in the CRC home test program and test which elements of a reminder letter improve response rates.

    The quantitative component consists of a four-arm reminder letter randomized controlled trial (RCT) comparing no letter, standard letter, behaviorally informed letter, and behaviorally informed letter sent with a home testing kit to investigate the effectiveness of reminders in increasing uptake of home-testing for colorectal cancer. Recruitment and data collection for the reminder letter trial will be conducted utilizing the routine screening process and routinely collected screening data.

  2. Qualitative: conducting in-depth interviews with people from the target population who did or did not respond to the CRC invite letter and reminder to better understand the barriers and drivers to participation.

The qualitative component consists of 24 in-depth interviews (IDIs) conducted with members of the target population to identify barriers and drivers to completing colorectal cancer screening home-testing. Data collection for IDIs will be face-to-face, using discussion guides, and will be audio recorded. The audio-recordings will then be analyzed using a rapid analysis approach based on by the modified Capability-Opportunity-Motivation-Behavior (COM-B) framework.

02

Conditions studied

  • Colorectal Cancer
  • Behavior Change

Keywords

  • colorectal cancer
  • cancer screening
  • behavioral insights
  • communications
03

In context

Colorectal Neoplasms

5,599 studies on the registry are indexed under Colorectal Neoplasms; 1,459 are open to participants now.

This study's planned enrollment of 13,000 is above the median of 77 across 4,123 interventional studies indexed under Colorectal Neoplasms.

Browse Colorectal Neoplasms studies →

Lead sponsor

This is the only study on the registry with Veerle Snijders as lead sponsor.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
50 Years to 74 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • eligible to participate in the national colorectal cancer screening programme
  • live in a study location (Split-Dalmatia or Zagreb City counties)
  • did not respond to the cancer screening invite letter

Exclusion criteria

Exclusion Criteria:

  • participated in the colorectal screening programme in the last 24 months
05

Study design

Phase
Not applicable
Primary purpose
Screening
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
13,000 participants (estimated)

Study arms

  • No intervention
    Control

    Participants do not receive a reminder letter, which is treatment as usual.

  • Experimental
    Standard letter

    Participants receive a reminder letter which is based on the current colorectal cancer screening invitation.

    Behavioral: Standard letter

  • Experimental
    Behaviorally informed letter

    Participants receive a reminder letter which incorporates several behavioral components, including an active choice prompt, social norm, simplification, chunking and call to action.

    Behavioral: Behaviorally informed letter

  • Experimental
    Behaviorally informed letter + testing kit

    Participants receive the behaviorally informed letter plus the colorectal home testing kit, which removes the current barrier of having to request a kit.

    Behavioral: Behaviorally informed letter · Behavioral: Home testing colorectal cancer kit

Interventions

  • BehavioralStandard letter

    A reminder letter to encourage recipients to order the colorectal cancer home testing kit, based on the current invite letter.

  • BehavioralBehaviorally informed letter

    A reminder letter to encourage recipients to order the colorectal cancer home testing kit, with incorporates severally behaviorally informed components, including an active choice prompt, social norm, call to action, chunking and simplification.

  • BehavioralHome testing colorectal cancer kit

    The home testing kit is included with the reminder letter, instead of the usual process of responding to the letter to order the kit

06

What researchers measure

Primary outcomes

  1. Home test kit ordered

    Did the participant order the colorectal cancer home testing kit? Routinely collected data.

    Time frame: 5 weeks

  2. Completed colorectal cancer screening

    Did the participant complete the home testing kit and return it to the health authority? Routinely collected data.

    Time frame: 5 weeks

Secondary outcomes

  1. Opted out

    Did the participant actively opt out of participating in the screening program? Routinely collected data.

    Time frame: 5 weeks

  2. Qualitative feedback

    Qualitative feedback on the intervention arms and colorectal cancer screening experience. Collected through 24 semi-structured interviews.

    Time frame: 10 weeks

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: No — The study utilizes the data that is routinely collected as part the Croatian National Screening Database, only specific approved members of the screening program are able to access and utilize this data. For this reason, it is currently not planned to share individual participant data.

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 2, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06341322
Lead sponsor
Veerle Snijders
Collaborators
Croatian Institute of Public Health, Andrija Štampar School of Public Health
Responsible party
Veerle Snijders (Behavioural Scientist, World Health Organization) — Sponsor-investigator
First posted
Apr 2, 2024
Start date
Mar 5, 2024
Primary completion
Apr 2024 (estimated)
Completion
Jul 2024 (estimated)
Last update
Apr 2, 2024

Study contacts

Veerle Snijders
Contact
snijdersv@who.int
+31642641587
Tiina Likki
Contact
likkit@who.int
+4531396157

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion